Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity.

Abstract

The human myeloid leukemias are a diverse group of disorders characterized by massive clonal expansion of myeloid cells showing variable degrees of differentiation block. Leukemic dendritic cells were generated in culture from chronic myelogenous leukemia (CML). These were used to stimulate autologous T cells to develop leukemia-specific cytotoxicity… (More)

Topics

Cite this paper

@article{Choudhury1998HumanLD, title={Human leukemia-derived dendritic cells: ex-vivo development of specific antileukemic cytotoxicity.}, author={Amit Choudhury and Antoine Toubert and Shailen Sutaria and Dominique J. Charron and R. E. Champlin and David F. Claxton}, journal={Critical reviews in immunology}, year={1998}, volume={18 1-2}, pages={121-31} }